Topiramate and Speech impairment (adult) - a phase IV clinical study of FDA data

Summary:

Speech impairment (adult) is reported as a side effect among people who take Topiramate (topiramate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lamotrigine, and have Seizures.

The phase IV clinical study analyzes which people have Speech impairment (adult) when taking Topiramate. It is created by eHealthMe based on reports of 48,099 people who have side effects when taking Topiramate from the FDA, and is updated regularly.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.

What is Speech impairment (adult)?

Speech impairment (adult) (inability to speak (adult)) is found to be associated with 2,137 drugs and 3,592 conditions by eHealthMe. Check the latest studies of Speech impairment (adult).

On Jul, 10, 2026

48,099 people reported to have side effects when taking Topiramate.
Among them, 692 people (1.44%) have Speech impairment (adult).

Could Topiramate cause Speech impairment (adult)?

Among these 692 people:

How long have people been on Topiramate when they have Speech impairment (adult)? *

Click here to view more results

What is the gender of people who have Speech impairment (adult) when taking Topiramate? *

Click here to view

What is the age of people who have Speech impairment (adult) when taking Topiramate? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Topiramate and have Speech impairment (adult)?

- Check whether Speech impairment (adult) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Topiramate:

Topiramate (49,809 reports)

Speech impairment (adult) treatments and more:

Speech impairment (adult) (82,511 reports)

How severe was Speech impairment (adult) and when was it recovered:

Speech impairment (adult) in Topiramate

Expand to all the drugs that have ingredients of topiramate:

Speech impairment (adult) and drugs with ingredients of topiramate (1,539 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech impairment (adult):

Speech impairment (adult) (2,137 drugs)

Browse all the conditions that are associated with Speech impairment (adult):

Speech impairment (adult) (3,592 conditions)

Related publications that referenced our studies

Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on topiramate (the active ingredients of Topiramate) and Topiramate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.